In the news

Most Read

  • Telkom CEO Sipho Maseko to step down
    Telkom has announced that its CEO and executive director Sipho Maseko will step down on 30 June 2022. The telecoms company said the process to appoint a successor is well underway and a designated group CEO will be announced in the not too distant future.
  • How cooking oil brought a moment of joy during a dreadful week
    It is possible that cooking oil prevented more looting in South Africa in the last week than the president, the ANC, the intelligence community, the army and the police combined. This, without question, says something about the versatility of the product. It says even more about the state of the state. When you are shown up by canola, you might want to revisit your strategy. By Howard Feldman
  • Park Advertising launches digital performance unit, Lucid Media
    Performance Media across Search, Social and Programmatic platforms is the single fastest growing area of digital media in South Africa. Combine that with the detailed analysis of campaign management, tagging and ad operations, and it becomes apparent that these highly specialist functions require a highly specialised unit.
  • Transnet hit by cyberattack - Operations disrupted nationwide
    The Transnet Port Terminals website has been hacked, implying that all companies under Transnet have been affected. All Transnet websites were down at the time when reporting was done for this SA Trucker article. The publication cited sources who requested to remain anonymous because they are not allowed to speak to the media.
  • #BehindtheBrandManager: Meet Tamsin Darroch of Kellogg's South Africa
    Few food brands have the historical connection with consumers around the world as Kellogg's does, having held meaning at the breakfast table for over a century. By Lauren Hartzenberg
  • Business unusual for small enterprises on the road to recovery
    The Covid-19 pandemic has hit South Africa's small business sector hard and there are grim statistics to bear this out. Those statistics will not be repeated here. After all, if you are a small business owner setting out on the road to recovery, the last thing you probably want is more details of the toll the pandemic has taken on small enterprises. Far more useful would be some good, solid tips on how to build back better after any business setbacks. By Ameen Hassen
Show more
Advertise on Bizcommunity

Subscribe to industry newsletters

Study: HIV and TB co-infection skews Covid-19 T cell response

New research by scientists at the University of Cape Town examined the relationship between SARS-CoV-2-specific CD4 response to Covid-19 severity and impact of HIV and tuberculosis (TB) co-infection.
Source: ©Penchan Pumila
The researchers assessed the magnitude, function and phenotype of SARS-CoV-2-specific CD4 T cells in 95 hospitalised Covid-19 patients (38 of them being HIV and/or TB co-infected) and 38 non-Covid-19 patients, using flow cytometry.

“We found that SARS-CoV-2-specific CD4 T cell attributes, rather than magnitude, associates with disease severity, with severe disease being characterised by poor polyfunctional potential and reduced proliferation capacity,” said Dr Catherine Riou, lead researcher and senior research officer at UCT’s Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa).

“HIV and TB co-infection skewed the SARS-CoV-2 immune response. HIV mediated CD4 T cell depletion associated with suboptimal T cell and antibody responses to SARS-CoV-2 and a decrease in the polyfunctional capacity of SARS-CoV-2-specific CD4 T cells was observed in Covid-19 patients with active TB,” said Riou. “These results corroborate the important role of SARS-CoV-2-specific T cells in Covid-19 pathogenesis and support the concept of altered T cell functions in patients with severe disease.”

The results also revealed that Covid-19 patients displayed reduced frequency of Mycobacterium tuberculosis-specific CD4 T cells.

Heightened risk

Many viruses, including SARS-CoV-2, cause a temporary immunosuppressive effect, which could lead to the reactivation of subclinical bacterial infection. Thus, in a TB-endemic country such as South Africa, many concerns have been raised about the possibility that Covid19 could reactivate latent TB, Professor Robert J Wilkinson, co-author and director of CIDRI-Africa, said

He suggested that HIV infected patients with SARS-CoV-2 need to be started on antiretroviral therapy (ART) if not already established. “HIV infected persons should be stabilised on ART and then prioritised for vaccination. The co-occurrence of TB reduces the effectiveness of the anti- SARS-CoV-2 immune response and TB should be suspected as a complication of SARS-CoV2."

Associate Professor Katalin Wilkinson, principal laboratory research scientist at the Francis Crick Institute in London, commented: “The clinical and epidemiological interactions of Covid-19 with TB and/or HIV pose an additional health threat. Although comorbidities associated with HIV and TB may primarily drive Covid-19 severity in these populations, it is also plausible that HIV and/or TB-associated immune dysregulation may contribute to heightened risk.”

Read more: HIV/AIDS, TB
Let's do Biz